Presented by Dr. Dmitry Pugachevsky, Director of Research at Quantifi; and Dr. Roman Bedau, Consultant at Deloitte Germany, the webinar focused on the following:
- Challenges and implications of measuring financial instruments under IFRS 13
- Review of the different fair value adjustments
- Risk factors specific to model-based fair value measurements
- Concepts for calculating complex variables: CVA, DVA and FVA (XVA)
Quantifi is a specialist provider of analytics, trading and risk management solutions. Founded in 2002, Quantifi has over 140 clients across 16 countries including 5 of the 6 largest global banks, 2 of the 3 largest asset managers, leading hedge funds, pension funds, insurers, brokers, clearing members, corporates and other financial institutions. The client base is evenly divided between the sell and buy-side. Quantifi has offices in London, New York, Frankfurt, Paris, New Jersey, and Sydney.
Quantifi re-invests significantly into research and development each year. We work closely with clients, market experts, and industry participants to drive our products. Reflecting this long term commitment, Quantifi has an unparalleled track record of being first-to-market for all of the most significant innovations in the OTC markets including CVA, FVA and OIS/CSA Discounting. Quantifi is also a leader in financial technology with early adoption of key technologies that give our clients advantages in terms of speed, scalability, and usability including being the first commercial native .NET analytics library and the first financial software vendor to support the Intel TBB multi-core API.